Wearable Injectors Market Size, Share & Trends Analysis Report By Type (On-body, Off-body), By Technology (Spring-based, Motor-driven, Rotary Pump, Expanding Battery, Other), By End Use, By Region, And Segment Forecasts, 2022 - 2030

Wearable Injectors Market Growth & Trends

The global wearable injectors market size is expected to reach USD 23.89 billion by 2030, registering a CAGR of 15.29% during the forecast period, according to new report by Grand View Research, Inc. The market is expected to witness lucrative growth during the forecast period owing to technological advancements in wearable injectors coupled with rising demand for round-the-clock monitoring.

Technological advancements in wearable injectors, for instance, Bluetooth integrated wearable injectors, send alerts to patients, such as injection reminders and data regarding their therapy regime. Also, optional smart functionality provides connectivity to the healthcare network. Some of these devices have buttons that are accessible through clothing, and some devices prevent accidental activation. They also have audible and visual status indicators or signals. Patients can self-administer drugs subcutaneously with minimal time and effort as compared to intravenous or other routes. Patients don’t need to visit any healthcare provider for the administration.

The prevalence of lifestyle-associated diseases, such as diabetes and hypertension is expected to increase during the forecast period. These diseases demand round-the-clock monitoring of various physiological parameters, such as blood pressure and blood sugar levels. The advanced ecosystem of these devices helps healthcare care providers to access data from remote location, which reduces clinical decision time. Thus, integration of healthcare data with wearable injectors, which gets forwarded to physicians or doctors giving them real-time access to data with reduced errors, is expected to boost the wearable injectors market.

Wearable Injectors Market Report Highlights

  • The on-body segment held a lucrative market share in 2021 owing to the growing preference of the patients for adhesive patches that release the drug conveniently and can be worn on the skin
  • The motor-driven segment is expected to register the highest growth during the forecast period owing to increasing demand from hospitals, clinics, retail chain stores, and pharmacies
  • The oncology segment is expected to hold the largest market share due to the globally increasing incidences of cancer
  • The home care segment is expected to dominate the market with the highest market share owing to increasing inclination towards the home-based treatments onset of Covid-19 pandemic can be seen and it has positively impacted the home care segment growth
  • North America is expected to dominate the wearable injectors market during the forecast period due to the rising demand for innovative IT solutions to streamline workflows, coupled with increasing regulatory requirements to ensure patient safety
Please note The report will be delivered in 2-8 business days upon order notification.


Chapter 1. Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Type
1.1.2 Technology
1.1.3 Application
1.1.4 End-use
1.1.5 Regional Scope
1.1.6 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.3.5.1 Data for primary interviews in North America
1.3.5.2 Data for Primary Interviews in Europe
1.3.5.3 Data for Primary Interviews in APAC
1.3.5.4 Data for Primary Interviews in Latin America
1.3.5.5 Data for Primary Interviews in MEA
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective 1
1.9.2 Objective 2
1.9.3 Objective 3
1.9.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 Wearable Injectors Market Variables, Trends & Scope
3.1 Penetration & Growth Prospect Mapping
3.2 Market Dynamics
3.2.1 Market Drivers Analysis
3.2.1.1 Increasing prevalence of chronic disorders and rising preference for early disease diagnosis
3.2.1.2 Rising demand for home-based healthcare due to Covid-19
3.2.1.3 Increasing preference for non-invasive technology
3.2.1.4 Increasing concern over the hazards related to needle stick injuries
3.2.2 Market Restraint Analysis
3.2.2.1 Dangers associated with traditional infusion and injection technology
3.2.2.2 Alternative drug delivery methods
3.2.2.3 Absence of favorable reimbursement policies
3.3 Wearable Injectors: Market Analysis Tools
3.3.1 SWOT Analysis by PESTEL
3.3.2 Industry Analysis-Porter’s Five Forces Analysis
3.4 Impact of COVID-19
3.4.1 COVID-19 Impact analysis
3.4.2 Impact on market players
Chapter 4 Wearable Injectors Market: Segment Analysis, By Type, 2017 - 2030 (USD Million)
4.1 Definitions and Scope
4.2 Type Market Share Analysis
4.3 Segment Dashboard
4.4 Wearable Injectors Market by Type
4.5 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
4.5.1 On-body
4.5.1.1 On-body Market Estimates and Forecast, 2017 - 2030 (USD Million)
4.5.2 Off-body
4.5.2.1 Off-body Market Estimates and Forecast, 2017 - 2030 (USD Million)
Chapter 5 Wearable Injectors Market: Segment Analysis, By Technology, 2017 - 2030 (USD Million)
5.1 Definitions and Scope
5.2 Technology Market Share Analysis
5.3 Segment Dashboard
5.4 Wearable Injectors Market by Technology
5.5 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
5.5.1 Spring-based
5.5.1.1 Spring-based Market Estimates and Forecast, 2017 - 2030 (USD Million)
5.5.2 Motor-driven
5.5.2.1 Motor-driven Market Estimates and Forecast, 2017 - 2030 (USD Million)
5.5.3 Rotary Pump
5.5.3.1 Rotary Pump Market Estimates and Forecast, 2017 - 2030 (USD Million)
5.5.4 Expanding Battery
5.5.4.1 Expanding Battery Market Estimates and Forecast, 2017 - 2030 (USD Million)
5.5.5 Others
5.5.5.1 Others Market Estimates and Forecast, 2017 - 2030 (USD Million)
Chapter 6 Wearable Injectors Market: Segment Analysis, By Application, 2017 - 2030 (USD Million)
6.1 Definitions and Scope
6.2 Application Market Share Analysis
6.3 Segment Dashboard
6.4 Wearable Injectors Market by Application
6.5 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
6.5.1 Oncology
6.5.1.1 Oncology Market Estimates and Forecast, 2017 - 2030 (USD Million)
6.5.2 Infectious Disease
6.5.2.1 Infectious Disease Market Estimates and Forecast, 2017 - 2030 (USD Million)
6.5.3 Cardiovascular Disease
6.5.3.1 Cardiovascular Disease Market Estimates and Forecast, 2017 - 2030 (USD Million)
6.5.4 Autoimmune Disease
6.5.4.1 Autoimmune Disease Market Estimates and Forecast, 2017 - 2030 (USD Million)
6.5.5 Immunodeficiency
6.5.5.1 Immunodeficiency Market Estimates and Forecast, 2017 - 2030 (USD Million)
6.5.6 Others
6.5.6.1 Others Market Estimates and Forecast, 2017 - 2030 (USD Million)
Chapter 7 Wearable Injectors Market: Segment Analysis, By End-use, 2017 - 2030 (USD Million)
7.1 Definitions and Scope
7.2 End-Use Market Share Analysis
7.3 Segment Dashboard
7.4 Wearable Injectors Market by End-use
7.5 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
7.5.1 Hospitals
7.5.1.1 Hospitals market Estimates and Forecast, 2017 - 2030 (USD Million)
7.5.2 Clinics
7.5.2.1 Clinics market Estimates and Forecast, 2017 - 2030 (USD Million)
7.5.3 Home Care
7.5.3.1 Home Care market Estimates and Forecast, 2017 - 2030 (USD Million)
7.5.4 Others
7.5.4.1 Others market Estimates and Forecast, 2017 - 2030 (USD Million)
Chapter 8 Wearable Injectors Market: Regional Market Analysis, 2017 - 2030 (USD Million)
8.1 Regional Market Dashboard
8.2 Definitions and Scope
8.3 Regional Market Share Analysis
8.4 North America
8.4.1 North America market estimates and forecast, 2017 - 2030
8.4.2 U.S.
8.4.2.1 U.S. market estimates and forecast, 2017 - 2030
8.4.3 Canada
8.4.3.1 Canada market estimates and forecast, 2017 - 2030
8.5 Europe
8.5.1 Europe market estimates and forecast, 2017 - 2030
8.5.2 U.K.
8.5.2.1 U.K. market estimates and forecast, 2017 - 2030
8.5.3 Germany
8.5.3.1 Germany market estimates and forecast, 2017 - 2030
8.5.4 France
8.5.4.1 France market estimates and forecast, 2017 - 2030
8.5.5 Italy
8.5.5.1 Italy market estimates and forecast, 2017 - 2030
8.5.6 Spain
8.5.6.1 Spain market estimates and forecast, 2017 - 2030
8.6 Asia Pacific
8.6.1 Asia Pacific market estimates and forecast, 2017 - 2030
8.6.2 Japan
8.6.2.1 Japan market estimates and forecast, 2017 - 2030
8.6.3 China
8.6.3.1 China market estimates and forecast, 2017 - 2030
8.6.4 India
8.6.4.1 India market estimates and forecast, 2017 - 2030
8.6.5 Australia
8.6.5.1 Australia market estimates and forecast, 2017 - 2030
8.6.6 South Korea
8.6.6.1 South Korea market estimates and forecast, 2017 - 2030
8.7 Latin America
8.7.1 Latin America market estimates and forecast, 2017 - 2030
8.7.2 Mexico
8.7.2.1 Mexico market estimates and forecast, 2017 - 2030
8.7.3 Brazil
8.7.3.1 Brazil market estimates and forecast, 2017 - 2030
8.7.4 Argentina
8.7.4.1 Argentina market estimates and forecast, 2017 - 2030
8.7.5 Colombia
8.7.5.1 Colombia market estimates and forecast, 2017 - 2030
8.8 Middle East and Africa
8.8.1 Middle East and Africa market estimates and forecast, 2017 - 2030
8.8.2 South Africa
8.8.2.1 South Africa market estimates and forecast, 2017 - 2030
8.8.3 Saudi Arabia
8.8.3.1 Saudi Arabia market estimates and forecast, 2017 - 2030
8.8.4 UAE
8.8.4.1 UAE market estimates and forecast, 2017 - 2030
Chapter 9 Wearable Injectors Market - Competitive Analysis
9.1 Kind of Competition
9.2 Concentration of Market Players
9.3 Company Market Share Analysis
9.4 Categorization based on the Company’s Vision
9.5 Company Profiles
9.5.1 Becton, Dickinson and Company
9.5.1.1 Company overview
9.5.1.2 Financial performance
9.5.1.3 Product benchmarking
9.5.1.4 Strategic initiatives
9.5.2 Johnson & Johnson Services, Inc.
9.5.2.1 Company overview
9.5.2.2 Financial performance
9.5.2.3 Product benchmarking
9.5.2.4 Strategic initiatives
9.5.3 F. Hoffmann-La Roche Ltd.
9.5.3.1 Company overview
9.5.3.2 Financial performance
9.5.3.3 Product benchmarking
9.5.3.4 Strategic initiatives
9.5.4 Unilife Corporation
9.5.4.1 Company overview
9.5.4.2 Financial performance
9.5.4.3 Product benchmarking
9.5.4.4 Strategic initiatives
9.5.5 SteadyMed Therapeutics, Inc.
9.5.5.1 Company overview
9.5.5.2 Financial performance
9.5.5.3 Product benchmarking
9.5.5.4 Strategic initiatives
9.5.6 Amgen Inc.
9.5.6.1 Company overview
9.5.6.2 Financial performance
9.5.6.3 Product benchmarking
9.5.6.4 Strategic initiatives
9.5.7 Insulet Corporation
9.5.7.1 Company overview
9.5.7.2 Financial performance
9.5.7.3 Product benchmarking
9.5.7.4 Strategic initiatives
9.5.8 Enable Injections
9.5.8.1 Company overview
9.5.8.2 Financial performance
9.5.8.3 Product benchmarking
9.5.8.4 Strategic initiatives
9.5.9 West Pharmaceutical Services, Inc.
9.5.9.1 Company overview
9.5.9.2 Financial performance
9.5.9.3 Product benchmarking
9.5.9.4 Strategic initiatives
9.5.10 CeQur SA
9.5.10.1 Company overview
9.5.10.2 Financial performance
9.5.10.3 Product benchmarking
9.5.10.4 Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings